These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 22072759)

  • 1. Escape from a dominant HLA-B*15-restricted CD8+ T cell response against hepatitis C virus requires compensatory mutations outside the epitope.
    Ruhl M; Chhatwal P; Strathmann H; Kuntzen T; Bankwitz D; Skibbe K; Walker A; Heinemann FM; Horn PA; Allen TM; Hoffmann D; Pietschmann T; Timm J
    J Virol; 2012 Jan; 86(2):991-1000. PubMed ID: 22072759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct Escape Pathway by Hepatitis C Virus Genotype 1a from a Dominant CD8+ T Cell Response by Selection of Altered Epitope Processing.
    Walker A; Skibbe K; Steinmann E; Pfaender S; Kuntzen T; Megger DA; Groten S; Sitek B; Lauer GM; Kim AY; Pietschmann T; Allen TM; Timm J
    J Virol; 2016 Jan; 90(1):33-42. PubMed ID: 26446603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Escape from HLA-B*08-restricted CD8 T cells by hepatitis C virus is associated with fitness costs.
    Salloum S; Oniangue-Ndza C; Neumann-Haefelin C; Hudson L; Giugliano S; aus dem Siepen M; Nattermann J; Spengler U; Lauer GM; Wiese M; Klenerman P; Bright H; Scherbaum N; Thimme R; Roggendorf M; Viazov S; Timm J
    J Virol; 2008 Dec; 82(23):11803-12. PubMed ID: 18815309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human leukocyte antigen B27 selects for rare escape mutations that significantly impair hepatitis C virus replication and require compensatory mutations.
    Neumann-Haefelin C; Oniangue-Ndza C; Kuntzen T; Schmidt J; Nitschke K; Sidney J; Caillet-Saguy C; Binder M; Kersting N; Kemper MW; Power KA; Ingber S; Reyor LL; Hills-Evans K; Kim AY; Lauer GM; Lohmann V; Sette A; Henn MR; Bressanelli S; Thimme R; Allen TM
    Hepatology; 2011 Oct; 54(4):1157-66. PubMed ID: 22006856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8+ T-cell response promotes evolution of hepatitis C virus nonstructural proteins.
    Ruhl M; Knuschke T; Schewior K; Glavinic L; Neumann-Haefelin C; Chang DI; Klein M; Heinemann FM; Tenckhoff H; Wiese M; Horn PA; Viazov S; Spengler U; Roggendorf M; Scherbaum N; Nattermann J; Hoffmann D; Timm J;
    Gastroenterology; 2011 Jun; 140(7):2064-73. PubMed ID: 21376049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive selection of cytotoxic T lymphocyte escape variants during acute hepatitis C virus infection.
    Guglietta S; Garbuglia AR; Pacciani V; Scottà C; Perrone MP; Laurenti L; Spada E; Mele A; Capobianchi MR; Taliani G; Folgori A; Vitelli A; Ruggeri L; Nicosia A; Piccolella E; Del Porto P
    Eur J Immunol; 2005 Sep; 35(9):2627-37. PubMed ID: 16114108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compensatory mutations restore the replication defects caused by cytotoxic T lymphocyte escape mutations in hepatitis C virus polymerase.
    Oniangue-Ndza C; Kuntzen T; Kemper M; Berical A; Wang YE; Neumann-Haefelin C; Foote PK; Hills-Evans K; Reyor LL; Kane K; Gladden AD; Bloom AK; Power KA; Thimme R; Lauer GM; Henn MR; Kim AY; Allen TM
    J Virol; 2011 Nov; 85(22):11883-90. PubMed ID: 21880756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino Acid Substitutions within HLA-B*27-Restricted T Cell Epitopes Prevent Recognition by Hepatitis Delta Virus-Specific CD8
    Karimzadeh H; Kiraithe MM; Kosinska AD; Glaser M; Fiedler M; Oberhardt V; Salimi Alizei E; Hofmann M; Mok JY; Nguyen M; van Esch WJE; Budeus B; Grabowski J; Homs M; Olivero A; Keyvani H; Rodríguez-Frías F; Tabernero D; Buti M; Heinold A; Alavian SM; Bauer T; Schulze Zur Wiesch J; Raziorrouh B; Hoffmann D; Smedile A; Rizzetto M; Wedemeyer H; Timm J; Antes I; Neumann-Haefelin C; Protzer U; Roggendorf M
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8 epitope escape and reversion in acute HCV infection.
    Timm J; Lauer GM; Kavanagh DG; Sheridan I; Kim AY; Lucas M; Pillay T; Ouchi K; Reyor LL; Schulze zur Wiesch J; Gandhi RT; Chung RT; Bhardwaj N; Klenerman P; Walker BD; Allen TM
    J Exp Med; 2004 Dec; 200(12):1593-604. PubMed ID: 15611288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of sequence variation in a dominant HLA-A*02-restricted epitope in hepatitis C virus on priming and cross-reactivity of CD8+ T cells.
    Ziegler S; Skibbe K; Walker A; Ke X; Heinemann FM; Heinold A; Mok JY; van Esch WJ; Yang D; Wölfl M; Timm J
    J Virol; 2014 Oct; 88(19):11080-90. PubMed ID: 25008925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation between viral fitness and immune escape within the hepatitis C virus protease.
    Söderholm J; Ahlén G; Kaul A; Frelin L; Alheim M; Barnfield C; Liljeström P; Weiland O; Milich DR; Bartenschlager R; Sällberg M
    Gut; 2006 Feb; 55(2):266-74. PubMed ID: 16105887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential escape of HCV from CD8
    Xia Y; Pan W; Ke X; Skibbe K; Walker A; Hoffmann D; Lu Y; Yang X; Feng X; Tong Q; Timm J; Yang D
    J Viral Hepat; 2019 Jan; 26(1):73-82. PubMed ID: 30260541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-B*27 subtype specificity determines targeting and viral evolution of a hepatitis C virus-specific CD8+ T cell epitope.
    Nitschke K; Barriga A; Schmidt J; Timm J; Viazov S; Kuntzen T; Kim AY; Lauer GM; Allen TM; Gaudieri S; Rauch A; Lange CM; Sarrazin C; Eiermann T; Sidney J; Sette A; Thimme R; López D; Neumann-Haefelin C
    J Hepatol; 2014 Jan; 60(1):22-9. PubMed ID: 23978718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27-restricted human immune response.
    Dazert E; Neumann-Haefelin C; Bressanelli S; Fitzmaurice K; Kort J; Timm J; McKiernan S; Kelleher D; Gruener N; Tavis JE; Rosen HR; Shaw J; Bowness P; Blum HE; Klenerman P; Bartenschlager R; Thimme R
    J Clin Invest; 2009 Feb; 119(2):376-86. PubMed ID: 19139562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of cross-reactive CD8+ T-cell recognition of HLA-A2-restricted HIV-Gag (SLYNTVATL) and HCV-NS5b (ALYDVVSKL) epitopes in individuals infected with human immunodeficiency and hepatitis C viruses.
    Vali B; Tohn R; Cohen MJ; Sakhdari A; Sheth PM; Yue FY; Wong D; Kovacs C; Kaul R; Ostrowski MA
    J Virol; 2011 Jan; 85(1):254-63. PubMed ID: 20980521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid antigen processing and presentation of a protective and immunodominant HLA-B*27-restricted hepatitis C virus-specific CD8+ T-cell epitope.
    Schmidt J; Iversen AK; Tenzer S; Gostick E; Price DA; Lohmann V; Distler U; Bowness P; Schild H; Blum HE; Klenerman P; Neumann-Haefelin C; Thimme R
    PLoS Pathog; 2012; 8(11):e1003042. PubMed ID: 23209413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimized vaccination regimen linked to exhaustive screening approaches identifies 2 novel HLA-B7 restricted epitopes within hepatitis C virus NS3 protein.
    Martin P; Parroche P; Pajot A; Chatel L; Barreto C; Touat L; Dubois V; Rohrlich PS; Bain C; Trépo C; Negro F; Inchauspé G; Fournillier A
    Microbes Infect; 2006 Aug; 8(9-10):2432-41. PubMed ID: 16859951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the evolutionary forces in an immunodominant CD8 epitope in hepatitis C virus at a population level.
    Neumann-Haefelin C; Frick DN; Wang JJ; Pybus OG; Salloum S; Narula GS; Eckart A; Biezynski A; Eiermann T; Klenerman P; Viazov S; Roggendorf M; Thimme R; Reiser M; Timm J
    J Virol; 2008 Apr; 82(7):3438-51. PubMed ID: 18216107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmitted/Founder Viruses Rapidly Escape from CD8+ T Cell Responses in Acute Hepatitis C Virus Infection.
    Bull RA; Leung P; Gaudieri S; Deshpande P; Cameron B; Walker M; Chopra A; Lloyd AR; Luciani F
    J Virol; 2015 May; 89(10):5478-90. PubMed ID: 25740982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
    López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
    J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.